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Abstract The selenoenzyme thioredoxin reductase (TR) can
recycle ascorbic acid, which in turn can recycle K-tocopherol.
Therefore, we evaluated the role of selenium in ascorbic acid
recycling and in protection against oxidant-induced loss of K-
tocopherol in cultured liver cells. Treatment of HepG2 or H4IIE
cultured liver cells for 48 h with sodium selenite (0^116 nmol/l)
tripled the activity of the selenoenzyme TR, measured as
aurothioglucose-sensitive dehydroascorbic acid (DHA) reduc-
tion. However, selenium did not increase the ability of H4IIE
cells to take up and reduce 2 mM DHA, despite a 25% increase
in ascorbate-dependent ferricyanide reduction (which reflects
cellular ascorbate recycling). Nonetheless, selenium supplements
both spared ascorbate in overnight cultures of H4IIE cells, and
prevented loss of cellular K-tocopherol in response to an oxidant
stress induced by either ferricyanide or diazobenzene sulfonate.
Whereas TR contributes little to ascorbate recycling in H4IIE
cells, selenium spares ascorbate in culture and K-tocopherol in
response to an oxidant stress. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Liver is the site of ascorbic acid biosynthesis in most mam-
mals. Liver is also capable of recycling the vitamin from its
two-electron oxidized form, dehydroascorbic acid (DHA).
Since humans lack the ability to synthesize ascorbic acid,
such recycling may help to supplement stores of the vitamin
supplied by diet. The capacity for DHA reduction by hepato-
cytes is substantial. For example, uptake and reduction of
DHA by cultured liver cell lines of both rat and human origin
is complete in several minutes [1]. In response to DHA load-
ing in these cell lines, ascorbate acutely reaches concentrations
of 5^20 mM [1,2], although the steady-state ascorbate concen-
tration in rat liver is about 1 mM [3].
In recent studies, we found that DHA reduction in cultured
liver cell lines is largely GSH-dependent [2]. GSH can reduce
DHA directly [4], or act as a co-factor for DHA reduction by
enzymes such as glutaredoxin and protein disul¢de isomerase
[5,6]. NADPH-dependent DHA reduction has also been de-
scribed in liver, and is mediated by 3K-hydroxysteroid dehy-
drogenase [7] and the selenoenzyme thioredoxin reductase
(TR) [3]. In extracts from liver, we found that more than
two-thirds of NADPH-dependent DHA reduction could be
attributed to TR, based on speci¢c inhibition by aurothioglu-
cose [3]. TR can also reduce the ascorbate free radical (AFR)
in liver [8], which brings up the question as to whether the TR
system in liver contributes signi¢cantly to the recycling of
ascorbate from its oxidized forms in this organ.
One approach to answering the above question is to modify
the endogenous activity of TR and determine whether that
a¡ects DHA reduction, either directly or indirectly through
e¡ects on ascorbate recycling. Since TR is a selenoenzyme,
and is inactive without selenium, its activity can be decreased
by lowering the amount of selenium available to an animal or
to cultured cells. In rats de¢cient in selenium due to dietary
deprivation, we found that dialyzed liver extracts had only
25% of the TR-dependent DHA reducing capacity of extracts
from control animals [3]. Moreover, the liver ascorbate con-
tent of selenium-de¢cient rats was decreased by 20^30% [3].
The selenium content in most tissue culture media is inad-
equate to maintain optimal activities of selenoenzymes such
as glutathione peroxidase [9], phospholipid hydroperoxide
glutathione peroxidase, and TR [10]. Therefore, in the present
studies we have modi¢ed the activity of TR by supplementing
selenium in culture and then assessed how this a¡ects the
ability of the cells to reduce DHA and to withstand an oxi-
dant stress. Whereas we were unable to show that selenium
de¢ciency a¡ects the ability of the cells to reduce DHA to
ascorbate, we did ¢nd that selenium supplements spare ascor-
bate and K-tocopherol in the cells.
2. Materials and methods
2.1. Materials
Sodium selenite was obtained from Sigma/Aldrich Chemical Co.
(St. Louis, MO, USA). DHA was prepared from ascorbate just before
use by bromine oxidation, as previously described [11].
2.2. Cell culture and modi¢cation of cell selenium content
HepG2 cells, which are derived from a human hepatocellular carci-
noma, were grown in six-well plates in Dulbecco’s modi¢ed Eagle’s
medium containing 10% (v/v) fetal calf serum. H4IIE cells, which are
derived from a rat hepatoma, were cultured in six-well plates in Dul-
becco’s modi¢ed Eagle’s medium containing 2.5% (v/v) fetal calf se-
rum and 2.5% newborn calf serum. The cell content of selenium was
modi¢ed as previously described [9]. Brie£y, cells cultured to con£u-
ence in six-well plates were cultured for 48 h in serum-free medium.
Selenium was added to the indicated concentration (0^116 nmol/l),
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and the incubation was continued for another 48 h in serum-free
medium before starting an experiment.
2.3. Measurement of TR-dependent DHA reduction
TR activity in overnight-dialyzed liver cell extracts was measured
following overnight dialysis of cell extracts. Cells were scraped from
four wells of a six-well plate in 1.5 ml of phosphate-bu¡ered saline
(PBS) and transferred to a microfuge tube. PBS was prepared using
de-ionized water to contain 12.5 mM sodium phosphate, 140 mM
sodium chloride, pH 7.4. The suspension was frozen in dry ice^ace-
tone and allowed to thaw on ice. The extract was microfuged at 3‡C
for 5 min at 13 000Ug. The supernatant was removed and centrifuged
at 3‡C for 1 h at 100 000Ug in a Beckman T-100 ultracentrifuge. The
resulting supernatant was dialyzed overnight against three changes of
Tris^EDTA bu¡er in dialysis tubing with a molecular weight cut-o¡
of 3500. The dialysate was then taken for assay of DHA reduction as
previously described [3].
2.4. Measurement of DHA uptake and reduction, and cell ascorbate
and of K-tocopherol
For measurement of DHA uptake and reduction, cells cultured in
six-well plates were rinsed three times in 2 ml of PBS at 37‡C. Freshly
prepared DHA was added to a concentration of 2 mM in PBS con-
taining 5 mM D-glucose. The cells were incubated for 30 min at 37‡C,
followed by rapid removal of the medium and one rinse in 2 ml of
PBS before assay of ascorbate in the cells.
The ascorbate content of rinsed cell monolayers in six-well plates
was determined as follows. Cells were lysed by addition of 0.5 ml of
ice cold 80% methanol (v/v) that contained 1 mM EDTA. After
scraping the cells from the dish using a rubber spatula, the lysate
from each well was removed and saved. Each well was rinsed again
with 0.5 ml of methanol/EDTA, and the methanolic solutions were
combined in a microfuge tube. Cell debris was pelleted in a microfuge
at 13 000Ug for 5 min at 3‡C. Aliquots of the supernatant were taken
for assay of ascorbate as previously described [12] using ion pair high-
performance liquid chromatography (HPLC) with electrochemical de-
tection. Ascorbate was expressed as a concentration inside the cells,
based on a measured intracellular water space of 2.8 Wl per mg pro-
tein, or 1 Wl per well of cells [2].
The K-tocopherol content of cultured liver cells was measured by
adding 0.1 ml of a 5 mg/ml solution of pyrogallol to each well con-
taining cells from which bu¡er had been removed, followed by 0.4 ml
of 3% (w/v) sodium dodecyl sulfate. The solution was mixed and the
cells were scraped from the plate with a rubber spatula. The suspen-
sion was removed from the plate to a glass culture tube on ice. An-
other aliquot of 0.2 ml of 3% sodium dodecyl sulfate was added, and
the remaining cell debris was transferred to the glass tube. The well
was rinsed with 0.7 ml of reagent alcohol (95 parts ethanol, ¢ve parts
methanol), and this was added to the cell extract and mixed by vor-
texing. Heptane (0.6 ml) was added to each tube, and mixed by vor-
texing for 2 min. The layers were allowed to separate and an aliquot
of the clear upper heptane phase was taken for assay of K-tocopherol
by HPLC using electrochemical detection [12].
2.5. Measurement of ferricyanide reduction
Cells that had been cultured for 48 h in the absence or presence of
116 nmol/l sodium selenite were rinsed twice with PBS and incubated
at 37‡C in PBS that contained 5 mM D-glucose and 1 mM DHA as
noted. After 15 min, ferricyanide was added to a concentration of
2 mM and the incubation was continued for an additional 30 min at
37‡C before aliquots of the medium were removed for determination
of ferrocyanide by the method of Avron and Shavit [13].
2.6. Data analysis and statistical methods
Data are expressed as mean þ S.D. from the indicated number of
experiments. Di¡erences between two treatments were analyzed by
paired t-testing, and between multiple treatments by one-way repeated
measures analysis of variance with post-hoc analysis by Tukey’s test,
using the statistical software SigmaStat 2.0 (Jandel Scienti¢c, San
Rafael, CA, USA).
3. Results
To determine whether TR might contribute to DHA reduc-
tion in cultured liver cells, it was ¢rst necessary to establish
that the activity of TR was increased by the selenium content
of the culture medium. This was done by treating either
H4IIE cells (Fig. 1A) or HepG2 cells (Fig. 1B) with varying
amounts of selenium in serum-free culture medium for 48 h,
then measuring TR activity as the ability of dialyzed extracts
to reduce DHA to ascorbate [3]. To enhance the activity of
TR and the speci¢city of the assay for the enzyme, dialysates
were treated with both thioredoxin and selenocystine [8]. To-
tal activity was doubled by increasing medium concentrations
of selenium in both cell lines. TR activity, measured as that
sensitive to 10 WM aurothioglucose [14], was increased by
selenium in both cell types by about three-fold over basal
(lower curves in each panel of Fig. 1). Further, most of the
increase due to selenium supplementation of the medium oc-
curred in the aurothioglucose-sensitive fraction. In both cell
types NADPH-dependent DHA reductase activity was satu-
rable, and was half-maximal at medium selenium concentra-
tions of 6^12 nmol/l. These results show that DHA reductase
activity in these cells is selenium-dependent, and is sensitive to
the amount of selenium available. Aurothioglucose-sensitive
DHA reductase activity was signi¢cantly higher in H4IIE cells
than in HepG2 cells across the range of selenium concentra-
tions supplemented (P6 0.05). Glutathione peroxidase activ-
ity also showed a saturable increase in activity with increasing
medium selenium, and was half-maximal at 6^12 nmol/l sele-
nium in both cell lines (results not shown). Because of the
Fig. 1. Concentration dependence of TR-dependent DHA reductase
activity on medium selenium supplements. HepG2 cells (A) or
H4IIE cells (B) were cultured for 48 h with the indicated concentra-
tion of selenium as described under Section 2. NADPH-dependent
DHA reductase activity was measured in dialyzed extracts prepared
from the cells and expressed as total activity (circles), or activity
that could be inhibited by 10 WM aurothioglucose (squares). Results
are shown as mean þ S.E.M. from six experiments with each cell
type, with an asterisk indicating P6 0.05 compared to the zero sele-
nium treatment.
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greater increase in DHA reductase activity with selenium in
H4IIE cells, these cells were used in further studies.
Having established that TR activity can be modi¢ed by
changes in the concentration of selenium in the cell culture
medium, we next tested the ability of the cells in culture to
reduce DHA to ascorbate. Despite use of conditions likely to
saturate DHA reduction (a 5 min time of uptake at 2 mM
DHA), there was no e¡ect of medium selenium on the ability
of H4IIE cells to take up and reduce DHA to ascorbate (re-
sults not shown). To determine whether a more subtle e¡ect of
selenium might be apparent on ascorbate action in the cell, we
studied the e¡ects of selenium addition to the culture medium
on the ability of H4IIE cells to reduce extracellular ferricya-
nide. Ferricyanide was used as an oxidant stress that would
derive electrons from intracellular ascorbate and provide an
index of maximal intracellular ascorbate recycling [15]. Basal
rates of ferricyanide reduction by H4IIE cells were increased
six-fold by incubation with DHA, from 1.7 þ 0.2 nmol/min/mg
protein, to 10.8 þ 0.9 nmol/min/mg protein (n = 7 experi-
ments). Culture of the cells in serum-free medium containing
116 nmol/l sodium selenite for 48 h did not a¡ect basal rates
of ferricyanide reduction, which were 2.2 þ 0.4 nmol/min/mg
protein. However, when cells were loaded with ascorbate by
treatment with DHA, H4IIE cells cultured in selenium-replete
medium showed a signi¢cant 25% increase in their ability to
reduce ferricyanide compared to selenium-de¢cient cells
(13.5 þ 1.0 nmol/min/mg protein, P6 0.05 compared to
10.7 þ 0.8 nmol/min/mg protein in control cells, n = 7 experi-
ments).
Despite the failure of selenium to increase acute reduction
of DHA by H4IIE cells, selenium treatment did increase the
ability of the cells to maintain intracellular ascorbate follow-
ing an overnight incubation with 100 WM ascorbate. As shown
in Fig. 2, the intracellular ascorbate concentration reached 4 mM
after ascorbate treatment, and was increased by 50^80%
above control across the range of selenium concentrations.
This increase in intracellular ascorbate could have been due
to increased recycling capacity, but also due to an enhanced
ability of the cells to defend against oxidant stress in culture.
To explore the latter possibility, the e¡ect of selenium supple-
ments to maintain K-tocopherol in H4IIE cells was evaluated.
In these cells, endogenous K-tocopherol concentrations are
very low, but can be supplemented by adding 100 WM K-to-
copherol to the culture medium the day before the experi-
ment. This increased the endogenous K-tocopherol concentra-
tion in H4IIE cells over 100-fold, from 0.22 þ 0.03 nmol/mg
protein (n = 6 determinations) to between 35 and 38 nmol/mg
protein, as shown in Table 1. Supplementing cells with 23
nmol/l selenium had no e¡ect on either endogenous
(0.22 þ 0.08 nmol/mg protein) or added K-tocopherol (37 þ 2
nmol/mg protein) in H4IIE cells. To determine whether sele-
nium supplementation can prevent loss of K-tocopherol in the
face of an acute oxidant stress, cells were treated with either
ferricyanide or diazobenzene sulfonic acid (DABS). These re-
agents were used because both ferricyanide [16] and DABS
[17] have been shown to oxidize K-tocopherol and increase
lipid peroxidation measured as F2-isoprostanes in human er-
ythrocytes. In cells loaded with 100 WM K-tocopherol, acute
treatment with either ferricyanide or DABS decreased the
supplemented K-tocopherol contents by about 45%, an e¡ect
that was nearly reversed in cells also treated with selenium
(Table 1). These results show that addition of selenium to
the culture medium improves the ability of H4IIE cells to
retain loaded ascorbate and K-tocopherol, the latter in re-
sponse to an acute oxidant stress.
4. Discussion
Selenium is necessary for full expression of selenium-depen-
dent enzymes and proteins in cultured cells [9,18^20]. In this
work we show that adding increasing amounts of selenium as
selenite to cultures of H4IIE and HepG2 liver cells increases
the activity of TR, measured as its ability to reduce DHA to
ascorbate (Fig. 1). Despite increased TR activity, selenium
Fig. 2. Preservation of ascorbate in H4IIE cells by selenium treat-
ment in culture. H4IIE cells were treated with the indicated sele-
nium concentration for 48 h as described under Section 2. On the
day before the experiment, cells were treated with 100 WM ascorbate
and cultured for an additional 16^18 h. The cells were rinsed three
times in 1 ml of PBS to remove the medium and taken for assay of
ascorbate. Data are shown from nine experiments as mean þ S.E.M.,
with an asterisk indicating P6 0.05 compared to the zero selenium
treatment.
Table 1
E¡ects of oxidants on the K-tocopherol content of H4IIE cells
Treatment Ferricyanide (n = 10) DABS (n = 7)
(3) Selenium, (3) oxidant 38 þ 2 35 þ 3
(3) Selenium, (+) oxidant 21 þ 2* 19 þ 3*
(+) Selenium, (+) oxidant 31 þ 2 33 þ 4
H4IIE cells were treated with or without selenium (23 nmol/l) for 48 h, and incubated with 100 WM K-tocopherol for 16 h. The cells were
rinsed three times with 2 ml of PBS and incubated for 30 min at 37‡C in PBS that contained 5 mM D-glucose and either 1 mM ferricyanide or
0.1 mM DABS, as indicated. At the end of the incubation, the cells were washed three times with 2 ml of PBS and taken for assay of K-toco-
pherol, which is expressed as nmol per mg protein. Results are shown as mean þ S.E.M. for the indicated number of experiments (n), with an
asterisk (*) indicating P6 0.05 compared to both control and selenium treatment.
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supplements did not increase the ability of either cell type to
take up and reduce a high concentration of DHA to ascorbate
over a period of 5 min. Previous results from this laboratory
indicate that under these conditions transport is not limiting
for DHA uptake and reduction [2]. Although TR may ac-
count for most of the NADPH-dependent DHA reduction
in liver [3], our failure to see an e¡ect of selenium on DHA
reduction suggests that TR plays little role in the initial re-
duction of DHA in these cells. The current results agree with
our previous conclusion that DHA reduction is mediated
largely by GSH in H4IIE cells [2]. However, we did ¢nd
that selenium treatment increased in the ability of H4IIE cells
to reduce ferricyanide in DHA-treated cells by 25%. Ascor-
bate-dependent ferricyanide reduction has been shown to re-
£ect the ability of cells to recycle ascorbate from its oxidized
forms [15,21]. Since DHA reduction is not increased, the in-
creased ferricyanide reduction may be due to recycling from
the AFR, which is also reduced by the TR system [8].
The e¡ect of selenium to increase ascorbate recycling, albeit
small, may contribute to the ability of selenium to spare as-
corbate in overnight cultures of H4IIE cells (Fig. 2). Whereas
this e¡ect could in part be due to TR, it could also be due to
enhanced ability of other selenoenzymes such as glutathione
peroxidase [9,18^20], and phospholipid hydroperoxide gluta-
thione peroxidase [19,20] to scavenge hydroperoxides gener-
ated by the cells in culture. This would in turn spare ascorbic
acid from destruction and result in higher intracellular ascor-
bate concentrations.
In addition to preserving ascorbate, selenium supplementa-
tion of H4IIE cells also spared K-tocopherol in response to an
acute oxidant stress induced by ferricyanide and DABS (Table
1). Most cells in culture are probably de¢cient in K-tocopherol
[20,22], and we found this to apply to H4IIE cells, in which K-
tocopherol was increased by two orders of magnitude by an
overnight treatment with 100 WM K-tocopherol. Acute treat-
ment of K-tocopherol-supplemented cells with ferricyanide
and DABS lowered K-tocopherol by almost 50%. In short-
term incubations with human erythrocytes, both ferricyanide
[23] and DABS [17] are limited to the extracellular space,
probably because of their size and charge. Therefore, the ob-
served sparing of K-tocopherol probably re£ects that present
in the plasma membrane. Others have shown that selenium
supplements of a variety of cell types can prevent cell lysis and
death following treatment with hydroperoxides [18,19,24]. Our
¢nding that selenium can spare K-tocopherol and ascorbate in
H4IIE cells may provide an additional mechanism by which
selenium can prevent oxidant-induced cell damage in cells that
contain physiologic amounts of the vitamins.
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